Computer Vision Syndrome Visual Sequelae
Launched by SOHAG UNIVERSITY · May 20, 2020
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
CVS-F3 is a survey form consisted of up to 30 questions regarding Computer Vision Syndrome (CVS) complains, thereafter a randomized sample of students will be subjected to complete ophthalmic examination including visual acuity and refractive measurements, intraocular pressure measurements, Slitlamp and fungus examinations, mfERG examinations. the sudents will be requested to decrease their screen time and the examinations will be repeated one month later.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - University students
- Exclusion Criteria:
- • Amblyopia
- • Anisometropia
- • strabismus
- • Previous eye surgery
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Trial Officials
Mohammed Iqbal, MD. PhP
Principal Investigator
Sohag University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials